Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Breast cancer

AstraZeneca
Cancer / Regional

AstraZeneca Breast Cancer Drug Extends Progression-Free Survival

June 12, 2026June 11, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …

AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More

AstraZeneca
Cancer / Regional

AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer

June 3, 2026June 2, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …

AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More
Breast Cancer Awareness
Regional

Susan G. Komen Expands Pennsylvania Fundraising Effort

May 11, 2026May 10, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Susan G. Komen plans to raise a combined $725,000 through breast cancer fundraising walks in Philadelphia and Pittsburgh this month as cancer advocacy groups face growing demand …

Susan G. Komen Expands Pennsylvania Fundraising Effort Read More

AstraZeneca
Cancer / Regional

FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use

March 20, 2026March 19, 2026 - by Timothy Alexander

WILMINGTON, DE — The U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental application for ENHERTU, a breast cancer treatment developed by AstraZeneca and Daiichi …

FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use Read More
AstraZeneca
Regional

DATROWAY Gains Priority Review for Aggressive Breast Cancer

February 12, 2026February 11, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for DATROWAY® (datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review by the U.S. Food and Drug Administration for …

DATROWAY Gains Priority Review for Aggressive Breast Cancer Read More

AstraZeneca
Regional

ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook

December 31, 2025December 30, 2025 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has received Breakthrough Therapy Designation from the U.S. Food and Drug …

ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook Read More
AstraZeneca
Regional

FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer

December 28, 2025December 26, 2025 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca PLC (NASDAQ: AZN) and Japan’s Daiichi Sankyo said the U.S. Food and Drug Administration has approved ENHERTU in combination with pertuzumab as a first-line treatment for …

FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer Read More

Care for HER
Regional

New Data Shows Care Model Dramatically Improves Black Breast Cancer Outcomes

December 21, 2025December 20, 2025 - by Timothy Alexander

ANNAPOLIS, MD & PHILADELPHIA, PA — Two national breast cancer nonprofits unveiled new research showing significant gains in health outcomes and quality of life for Black women with breast cancer, …

New Data Shows Care Model Dramatically Improves Black Breast Cancer Outcomes Read More
National Comprehensive Cancer Network
Regional / Research

New Research Funding Targets Gaps in Care for Stage Four Breast Cancer

December 19, 2025December 17, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program has announced new funding aimed at improving treatment and care delivery for people living with metastatic, or …

New Research Funding Targets Gaps in Care for Stage Four Breast Cancer Read More
Zombie Fun Run 5K
Regional

Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care

December 14, 2025December 12, 2025 - by Timothy Alexander

MOUNTVILLE, PA — Field of Screams turned adrenaline and community spirit into tangible impact this fall, raising $8,400 for the Pennsylvania Breast Cancer Coalition during its 13th annual Zombie Fun …

Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care Read More

Posts pagination

1 2 3 Next

Trending News

  • How Did ‘All Money Counts’ Allegedly Target Dozens of Victims?

  • Cockroach Infestation Tops Chester County Food Violations

  • SAMHSA Awards $73.2 Million to Expand Mental Health Programs

  • Impossible Hours? Care Attendants Charged in $1.5M Fraud Case

  • DOJ Alleges Massive Medicaid Fraud Scheme in Philadelphia

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Brandon J. Greisser

How Did ‘All Money Counts’ Allegedly Target Dozens of Victims?

August 5, 2026August 5, 2026

Office of the Attorney General

Impossible Hours? Care Attendants Charged in $1.5M Fraud Case

August 5, 2026August 5, 2026

Department of Justice

DOJ Alleges Massive Medicaid Fraud Scheme in Philadelphia

August 5, 2026August 5, 2026

Copyright © 2026 MyChesCo.